(Q40123049)

17 September 2017

1 reference

title

The regulation of complement activity by pharmacologic agents (English)

1 reference

17 September 2017

The Regulation of Complement Activity by Pharmacologic Agents (English)

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

author name string

A. M. Reynard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6256451

8 September 2023

language of work or name

1 reference

1 January 1980

1 reference

full work available at URL

17 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/08923978009026386

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Immunopharmacology and Immunotoxicology

8 September 2023

published in

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

1-47

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

17 September 2017

1 reference

Fluid phase destruction of C2hu by C1hu. II. Unmasking by C4ihu of C1hu specificity for C2hu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Inhibition of four human serine proteases by substituted benzamidines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Exo-site affinity labeling of C1.¯ a subcomponent of the first component of complement, by m-[o-(2-chloro-5-fluorosulfonylphenylureido)phenoxybutoxy]benzamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Observations on the ultrastructure of lesions induced in human and guinea pig skin by C 1 esterase and polypeptide from hereditary angioneurotic edema (HANE) plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Inhibition of the enzymatic activity of the first component of complement (C1) by heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

The reaction mechanism of human C5 in immune hemolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

C3 proactivator convertase and its mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

The anticomplementary effect of kidney tissue; its association with ammonia production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

The effect of a cobra venom factor on complement and adjuvant-induced disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Reaction mechanism of the alternative pathway of complement fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Inhibition of experimental autoimmune renal tubulointerstitial disease in guinea pigs by depletion of complement with cobra venom factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Effect of penicillamine on complement in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Chemotherapeutic drugs increase killing of tumor cells by antibody and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Correlation Between Lipid Synthesis in Tumor Cells and Their Sensitivity to Humoral Immune Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Membrane fluidity change in erythrocytes induced by complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Increased Fluidity of Human Platelet Membranes during Complement-Mediated Immune Platelet Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Adenosine 3'5'-monophosphate: inhibition of complement-mediated cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

1,10-Phenanthroline mediated hemolysis—evidence that 1,10-phenanthroline does not substitute specifically for C9

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

The combined actions of chloramphenicol and of bactericidal antibody plus complement on Salmonella typhosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Studies on the interaction between serum bactericidal activity and antibiotics in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Complement and contrast material reactors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Activation of the complement system by radiographic contrast media: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Passive sensitization of Salmonella adelaide to the bactericidal action of antibody and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Control of the amplification convertase of complement by the plasma protein beta1H

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Modulation of the alternative complement pathways by beta 1 H globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923978009026386

21 January 2018

The Complement System

3

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

The biochemistry of complement

8 September 2023

5

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Human complement: onset and site of synthesis during fetal life

8 September 2023

6

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Complement deficiency states

8 September 2023

7

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Complement: A Host Defense Mechanism Ready for Pharmacological Manipulation?

8 September 2023

9

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1

8 September 2023

12

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process

8 September 2023

13

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

The unactivated form of the first component of human complement, C1

8 September 2023

15

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effect of C1-inhibitor, benzamidine, and heat treatment on the hydrolytic activity of a subcomponent of the first component of human complement, C1s

8 September 2023

18

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides

8 September 2023

22

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Tranexamic Acid Therapy in Hereditary Angioneurotic Edema

8 September 2023

28

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Primary pulmonary hypertension favorable effect of isoproterenol

8 September 2023

33

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Treatment of acquired C1-inhibitor deficiency with danazol

8 September 2023

36

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Antibody and complement-mediated cytotoxicity of nucleated cells. Inhibition by the sera of patients with acute lymphoblastic leukemia

8 September 2023

44

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Babesia rodhaini: requirement of complement for penetration of human erythrocytes

8 September 2023

52

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyleneglycoltetraacetic acid.

8 September 2023

56

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid

8 September 2023

58

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection

8 September 2023

75

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Expression of HL-A Antigens on the Surface of Cultured Human Lymphoid Cells: Effect of Inhibitors of Protein and Nucleic Acid Synthesis

8 September 2023

77

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effect of Inhibitors of Macromolecular Synthesis on HL-A Antibody Mediated Lysis of Cultured Lymphoblasts1

8 September 2023

78

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effect of metabolic inhibitors on killing of tumor cells by antibody and complement

8 September 2023

79

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

81

35

3195

Segerling M.

1975

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

82

35

3204

Segerling H.

1975

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

84

37

1432

Schlager S. I.

1977

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Relationship between bactericidal action of complement and fluidity of cellular membranes

8 September 2023

89

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

98

39

3156

Lo T. N.

1979

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Complement: substitution of the terminal component in immune hemolysis by 1,10-phenanthroline

8 September 2023

106

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Tetracyclines and host-defense mechanisms

8 September 2023

109

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Tetracycline interference with the bactericidal effect of serum

8 September 2023

110

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

EFFECT OF WIDE-SPECTRUM ANTIBIOTICS ON BACTERICIDAL ACTIVITY OF HUMAN SERUM: IN VITRO AND IN VIVO

8 September 2023

112

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Potentiation of Antibiotic Bactericidal Activity by Normal Human Serum

8 September 2023

115

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

The Effects and Significance of Subminimal Inhibitory Concentrations of Antibiotics*

8 September 2023

116

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum

8 September 2023

119

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum

8 September 2023

120

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum

8 September 2023

121

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Activation of Complement by Radiographic Contrast Media: Generation of Chemotactic and Anaphylatoxin Activities

8 September 2023

122

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Complement activation following intravenous contrast material administration

8 September 2023

124

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Neutralization of human serum lysozyme by sodium polyanethol sulfonate but not by sodium amylosulfate

8 September 2023

127

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

The effect of zinc and other metals on complement hemolysis of sheep red blood cells in vitro.

8 September 2023

129

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Effects of zinc chloride on guinea pig complement component activity in vitro: concentration-dependent inhibition and enhancement

8 September 2023

131

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Inhibition of the terminal stage of complement-mediated lysis (reactive lysis) by zinc and copper ions

8 September 2023

132

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms

8 September 2023

137

1 reference

https://api.crossref.org/works/10.3109/08923978009026386

8 September 2023

Identifiers

1 reference

17 September 2017

1 reference